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a b s t r a c t
A critical challenge for environmental chemical risk assessment is the characterization and reduction of
uncertainties introduced when extrapolating inferences from one species to another. The purpose of this
article is to explore the challenges, opportunities, and research needs surrounding the issue of how genomics
data and computational and systems level approaches can be applied to inform differences in response to
environmental chemical exposure across species. We propose that the data, tools, and evolutionary framework of comparative genomics be adapted to inform interspecies differences in chemical mechanisms of
action. We compare and contrast existing approaches, from disciplines as varied as evolutionary biology, systems biology, mathematics, and computer science, that can be used, modiﬁed, and combined in new ways to
discover and characterize interspecies differences in chemical mechanism of action which, in turn, can be
explored for application to risk assessment. We consider how genetic, protein, pathway, and network information can be interrogated from an evolutionary biology perspective to effectively characterize variations in
biological processes of toxicological relevance among organisms. We conclude that comparative genomics
approaches show promise for characterizing interspecies differences in mechanisms of action, and further,
for improving our understanding of the uncertainties inherent in extrapolating inferences across species in
both ecological and human health risk assessment. To achieve long-term relevance and consistent use in
environmental chemical risk assessment, improved bioinformatics tools, computational methods robust to
data gaps, and quantitative approaches for conducting extrapolations across species are critically needed.
Speciﬁc areas ripe for research to address these needs are recommended.
© 2011 Elsevier Inc. All rights reserved.
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inferences from animal models to humans challenging in the context
of human health risk assessment, and inferences across species challenging in the context of ecological risk assessment. These differences
can be in dosimetry, exposure, metabolic pathways, and in homology
of genes, proteins, biochemistry, and physiology (National Research
Council, 2006). Because of these challenges, there is a need for
approaches to identify, understand, and, ideally, quantify interspecies
differences in chemical mechanism of action. A chemical's mechanism
of action is deﬁned here as the complete molecular sequence of events
between the interaction of the chemical with its target site(s) and
observation of the outcome(s) (Fig. 1). The mechanism of action can
include both toxicokinetic (e.g., chemical absorption, distribution,
metabolism, or excretion) and toxicodynamic events (e.g., changes at
the molecular, cellular, tissue, or organ level). Because a chemical's
mechanism of action has rarely been fully understood due to data limitations, the “mode of action” concept was developed for and applied to
human health risk assessment. A chemical's mode of action, or “MOA,”
has been functionally deﬁned as a key event, or a sequence of key
events, that a particular toxicity outcome is dependent upon (i.e., part
of the causal pathway and not a coincident event) (U.S. EPA, 2006).
However, increasing information on mechanism of action provided by
genomic and toxicogenomic studies (for example, see the Comparative
Toxicogenomics Database; ctd.mdibl.org) has revealed that numerous
environmental chemicals have multiple MOAs, in some cases affecting
multiple pathways. Therefore, we focus here on the types of genomics
data, resources, and associated computational tools that show promise
for characterizing interspecies differences in mechanisms of action,
and that will thereby improve our understanding of the uncertainties

Introduction
In the National Research Council's (NRC) 2007 report, Toxicity
Testing in the 21st Century: A Vision and a Strategy, they provided
a general plan for a transition to a new “pathway-based” paradigm
for toxicity testing and risk assessment (National Research Council,
2007). This strategy envisions the replacement of in vivo animal toxicology studies with in vitro molecular studies, and the use of these in
vitro studies in combination with computational models as the basis
for regulatory decision making. In response, the U.S. Environmental
Protection Agency (EPA) has developed its own strategic plan for
moving towards a toxicity pathway-based risk assessment paradigm
(U.S. EPA, 2009; www.epa.gov/spc/toxicitytesting). Genomics data,
resources, and tools are central to the execution of this future risk
assessment paradigm. In addition, they are also useful within the current paradigm of risk assessment, especially in the context of formulating evidence-based extrapolations from one population to another
and from one species to another. Indeed, one of the three key areas
identiﬁed by a Health and Environmental Sciences Institute (HESI)
survey in which genomics is perceived as having the greatest relevance and impact on toxicology is in the identiﬁcation of species differences (Pettit et al., 2010). Identifying and characterizing these
interspecies differences is requisite to better informing the extrapolation of chemical risk across species, including from test animals to
humans, and to understanding the uncertainties involved in this
process.
There can be important differences among species in their response
to chemical exposure, making the extrapolation of toxicological
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Fig. 1. Interspecies differences in chemical mechanism of action after environmental chemical exposure. Illustration of where differences between two species, rat and human, may
exist in response to chemical exposure. Human and rat are shown as example species because these species are often compared in human health risk assessment; other species
would be relevant examples for ecological risk assessment. Arrows with question marks represent potential biological differences in the toxicokinetic (TK) and toxicodynamic
(TD) mechanisms, and in the potential health effect/outcome. (ADME = absorption, distribution, metabolism, and excretion.) There are multiple, different scenarios encountered
for different chemicals in which some data on TK and/or TD are available for more than one species. For example, when comparing species for a chemical's mechanism of action
where the outcome of interest is similar across species, the differences in mechanism of action could be at the TK and/or TD level.
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inherent in extrapolating inferences across species in both human
health risk assessment and ecological risk assessment.
In regards to human health risk assessment, it is usually the case
for a given chemical that there are limited data available to establish
human relevance (e.g., epidemiological studies, human in vitro assays). In the absence of human data, the assumption that health effects observed in animal test models are similar to health effects in
humans is employed by EPA (for example, neurotoxicity risk assessment guidelines (U.S. EPA, 1998). Indeed, the current risk assessment
paradigm often relies on data from high dose-based animal toxicological assays and on multiple extrapolations – from endpoints in one
species to endpoints in another species, from high doses to low
doses, and from one population to another. These extrapolated inferences about the health effects of chemicals are some of the sources of
uncertainty inherent in risk assessment. Furthermore, like traditional
toxicology studies, many of the computational toxicology models currently being developed, such as virtual tissue models, are also based
on data from animal studies (www.epa.gov/ncct/virtual_liver; www.
epa.gov/ncct/v-Embryo; Shah and Wambaugh, 2010). For application
to human health risk assessment, inferences based on these types of
models will therefore also require extrapolating across species.
To transition to the NRC and EPA vision of toxicity “pathway-based”
risk assessment, the development and adoption of methods for recognizing perturbations to pathways, for identifying “toxicity pathways,”
and for comparing effects of toxicity pathway perturbations across
species will be crucial. It is expected that the increasing availability of
genome-wide data, genomics tools, and molecular mechanistic data
will enable the development of such methods, including new approaches for informing interspecies differences in chemical mechanism
of action (National Research Council, 2006, 2007; Benson and Di Giulio,
2007). To fully leverage the ﬂoodgate of molecular information that has
opened in the past decade, environmental chemical risk assessors will
need a toolbox of tested methodologies that can be used to inform interspecies differences. Currently, since environmental chemicals commonly lack a sufﬁcient human data set, it can be difﬁcult to assess the
relevance of health effects observed in animal-based toxicology studies
to human health risk assessment. Likewise, for species of concern in
ecological risk assessments, approaches for better identifying differences, characterizing uncertainties, and extrapolating inferences about
the toxic effects of environmental chemicals across multiple, differing
species are needed.
To help advance research and development in this area of environmental chemical risk assessment, in this article we compare and contrast existing approaches that can be used, modiﬁed, and combined in
new ways to discover and characterize interspecies differences in
chemical mechanism of action. The focus of this article is on the critical
review of the available comparative methods, and while some chemical
examples are provided to highlight the use of some methods, this article
does not include a comprehensive review of chemical examples. First,
from disciplines as varied as evolutionary biology, systems biology,
mathematics, and computer science, we compile and discuss methodologies for making simple to complex comparisons between and among
sets of information. These methodologies can be applied to comparative
analyses of molecules and molecular mechanisms, including comparisons across species of genomics data such as gene sequences, protein
sequences, mRNA transcript abundance, protein–protein interactions,
gene-protein interactions, etc. Second, we discuss the advantages and
limitations of these various comparative approaches. Third, we assess
some of the opportunities for applying these approaches within the current risk assessment structure, and we identify areas in need of further
development for use in toxicity pathway-based risk assessment.
Approaches to comparing species at the molecular level
In human health risk assessment, we often need to extrapolate
inferences about biological function and impairment thereof from
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non-human animals to humans, with the end goal of understanding
the human health impacts of environmental contaminants. The
mechanistic differences in responses to chemicals among different
species can occur at any point along the different levels of biological
organization in the continuum from exposure to endpoint (Fig. 1).
To improve interspecies extrapolations in risk assessment and to
reduce and characterize their associated uncertainties, we therefore
need the ability to compare these differing biological levels of information across species. Thanks to genomics, bioinformatics, and computational algorithms from various ﬁelds, this ability exists. The data
from genome projects and the tools of molecular biology have greatly
expanded our discovery and understanding of physiological traits on
a cellular and molecular basis, also enabling the examination of
chemical perturbations on these differing biological levels of organization (Mattes, 2006). And, the conceptual framework of evolutionary biology plus mathematical algorithms from graph theory and
complex network theory have provided the theoretical underpinnings and computational mechanisms needed for making comparisons and inferences across species. Here, we provide a compilation
and overview of existing approaches that can be utilized for interspecies comparisons of genomic information. These approaches were developed within varied disciplines for varied purposes but are binned
here by their relevance to differing levels of biological complexity —
from genes and proteins to pathways to complex biological networks.
Gene/protein level approaches
Scientiﬁc comparisons across species in biology started with
attempts to classify organisms based on their overall similarity of
observable traits, typically morphological traits. This comparison of
shared physical characteristics across species, known as phenetics,
has largely been superseded by cladistics (Hennig, 1965), in which
shared derived characters are compared to infer the evolutionary
relationships among organisms. These relationships are depicted by
cladograms, or evolutionary trees. As it became possible to reconstruct evolutionary relationships among species using molecules as
characters, cladistic analysis using comparisons of DNA, RNA, and
protein sequences (molecular phylogenetics) became the norm for
testing taxonomic hypotheses. Therefore, the earliest and simplest
molecular methods of inter-species comparisons were developed at
the level of proteins, genes, and non-coding DNA sequences.
The computationally intensive nature of aligning, analyzing, and
reconstructing evolutionary trees from molecular sequence data of
multiple species gave rise to various computational sequence alignment and phylogenetic analysis methods. Because the processes of
identifying the optimal multiple sequence alignment and/or the
optimal tree can be prohibitively computationally expensive, these
methods typically employ heuristic algorithms and scoring functions.
A plethora of computer programs have been developed for both multiple sequence alignment and for phylogenetic tree reconstruction;
for a fairly comprehensive listing of available programs and servers,
see evolution.genetics.washington.edu/phylip/software.html. Some
phylogenetic analysis methods, such as maximum parsimony, implicitly invoke an evolutionary model; some, such as maximum likelihood and Bayesian inference, explicitly employ models of evolution;
and others, such as neighbor-joining, are based on genetic distance
measures typically calculated using population genetics models of
genetic mutation versus genetic drift, or percent sequence similarity
(for reviews of phylogenetic methods, see Nielsen, 2005; and also
see Yang, 2006). In addition, further advancing our abilities to make
comparisons among species at the molecular level are the more
recent technological breakthroughs that have given rise to highthroughput genome sequencing, and the availability of genomics
data through open access online databases (see Table 1).
In the simplest scenario, the biological unit of interest for interspecies comparisons at the molecular level is a DNA sequence such as a
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gene, or a protein sequence (see Frazer et al., 2003 for a review of
methods). For example, given a gene or protein known to be involved
in the mechanism of action of a toxicant in rats, we could compare its
sequence to the sequence of its orthologous gene/protein in humans.
Orthologs are genes/proteins in different species that originated from
a common ancestral gene/protein separated by a speciation event, as
opposed to genes or proteins that are derived from gene duplication
events within a species. The usefulness of an ortholog comparison
approach for risk assessment lays in an assumption that evolutionary
conservation of a gene or protein sequence correlates with conservation of its function, which in turn corresponds to a conserved mechanism of action. Ortholog comparisons have proven useful in drug
target prediction in the ﬁeld of pharmacology (Searls, 2003;
Gunnarsson et al., 2008). However, while evolutionarily conserved
sequences are likely functionally conserved as well, recent analyses
of genomic data have revealed that many sequences serving a conserved function are not themselves conserved (Margulies et al.,
2007; Monroe, 2009; Wang and Zhang, 2009). Therefore, while
there is support for the assumption that highly evolutionarily conserved DNA and protein sequences reveal a selective constraint that
belies an important and preserved function, the absence of conserved
sequence across species does not guarantee the absence of a conserved function. In other words, while conserved sequences and
high non-synonymous to synonymous substitution rate ratios in proteins are good indicators of natural selection that is maintaining a
function by ‘constraining’ sequences from diverging over time, natural selection and the functional constraints it imposes may not always
be evident by examination of gene and protein primary sequence
information.
Since our goal is to make inferences across species about the function and/or relative expression of a gene or protein and, thereby, its

role in the mechanism of action of a toxic agent, indices of overall
sequence similarity, such as percent sequence similarity or percent
identity (PID) (Raghava and Barton, 2006), are of limited practical
use as stand alone methods. Put another way, although gene and protein sequence similarity between species are quantiﬁable, such measures do not provide insight into differences in the function of those
genes and proteins and how they may or may not affect the mechanism of action. Targeted approaches that compare changes within
functional domains, protein structure, or gene regulatory sites, in
addition to methods that compare changes in levels of protein
expressed, are more likely to be useful in extrapolating inferences
about gene and protein function across species. Of course, in cases
of genes and proteins with known roles in xenobiotic metabolism or
other well-studied disease processes, interspecies sequence differences among orthologs may already be documented and understood
(see Mattes, 2006 for a review), and thus could be used in risk assessment. For example, the pesticide vinclozolin is known to act as an
anti-androgen, binding to the androgen receptor (AR), thereby inhibiting androgen action by blocking binding of AR with endogenous
androgens. Since this and other chemicals have been found to have
such speciﬁc effects on one protein, approaches that compared the
AR sequence and its binding afﬁnity across species have been fruitful
(Hartig et al., 2007; Wilson et al., 2007). In the absence of such information, several in silico methods for determining the structure and
assessing the functional importance and functional similarities of proteins have been developed.
Because conserved sequences are good indicators of natural selection, several methods of comparative sequence analysis have been
developed to ﬁnd these conserved sequences across genomes and,
by inference, identify functionally important regions. Regions of
DNA identiﬁed this way include both protein-coding and non-

Table 1
Selection of widely-used databases useful for comparative toxicogenomics.
Publicly available database

Description

Website

BioCarta
Biomolecular Object Network Databank plus
(BONDplus)
Comparative Toxicogenomics Database (CTD)

Pathway database with graphical models
Integrates public and proprietary gene sequences and interactions
(includes GENESEQ and BINDplus)
Manually curated data describing interspecies chemical–gene/protein
interactions and chemical– and gene–disease relationships
Multiple sequence alignments of conserved protein domains drawing
from several databases
Manually curated protein–protein interactions
Genome browser for sequenced genomes
Protein sequences and structures. (includes other databases such as
UniProtKB, PROSITE, ENZYME, HAMAP)
Annotated collection of publicly available sequences
Standardized representation and annotation of gene and gene product
attributes using controlled vocabulary
Functional genomics data of array- and sequence-based data
Automated detection of homologs among several completely
sequenced eukaryotic genomes
Database system and analysis tools for protein interaction data
Computationally predicted database of human protein–protein
interactions (PPIs) and their worm, fruitﬂy and mouse interologs
Collection of manually drawn pathway maps representing molecular
interaction and reaction networks
Collection of disease entries capturing knowledge on genetic and
environmental perturbations
Database of molecular interactions and biological processes assembled
into pathways
Compendium of human genes and genetic phenotypes
Manually curated and peer-reveiwed database of pathways that
includes a species comparison tool
Archive of information about experimentally-determined structures
of proteins, nucleic acids, and complex assemblies
Comprehensive database of the structural and evolutionary relationships
among all proteins whose structure is known
Known and predicted protein-protein interactions
High throughput assay data for chemical compounds
Genome browser for sequenced genomes

http://www.biocarta.com
http://bond.unleashedinformatics.com

Conserved Domain Database (CDD)
Database of Interacting Proteins (DIP)
Ensembl
Expert Protein Analysis System (ExPasy)
Proteomics Server
GenBank
Gene Ontology (GO) database
Gene Expression Omnibus (GEO)
Homologene
IntAct
IntNetDB
KEGG PATHWAY
KEGG DISEASE
Nature Pathway Interaction Database (PID)
Online Inheritance in Man (OMIM)
Reactome
RCSB Protein Data Bank (PDB)
SCOP database
STRING
ToxCast
UCSD genome browser

http://ctd.mdibl.org
http://www.ncbi.nlm.nih.gov/cdd/cdd.shtml
http://dip.doe-mbi.ucla.edu
http://www.ensembl.org
http://www.expasy.org
http://www.ncbi.nlm.nih.gov/genbank
http://www.geneontology.org
http://www.ncbi.nlm.nih.gov/geo
http://www.ncbi.nlm.nih.gov/homologene
http://www.ebi.ac.uk/intact
http://hanlab.genetics.ac.cn/IntNetDB.htm
http://www.genome.jp/kegg/pathway.html
http://www.genome.jp/kegg/disease
http://pid.nci.nih.gov
http://www.ncbi.nlm.nih.gov/omim
http://www.reactome.org
http://www.pdb.org
http://scop.mrc-lmb.cam.ac.uk/scop
http://string.embl.de/
http://www.epa.gov/comptox/toxcast
http://genome.ucsc.edu
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coding elements. The comparative genomics methods used to ﬁnd
these evolutionarily conserved regions tend to incorporate and
build on one or more phylogenetic analysis methods. For example,
one type of approach uses maximum likelihood gene or protein
trees to infer relative evolutionary rates among multi-species
sequence alignments (e.g., the “Evolution–Structure–Function”
(ESF) analyses of Simon et al., 2002); another type develops statistically rigorous single-site measures of evolutionary conservation
using maximum likelihood analysis and models of nucleotide substitution (e.g., the “Genomic Evolutionary Rate Proﬁling” (GERP) of
Cooper et al., 2005; Goode et al., 2010); and yet another type makes
use of hidden Markov models whose parameters are estimated from
multiple alignment by maximum likelihood. Finally, by integrating
the results of several such alignment and conservation-detecting
approaches, Margulies et al. (2007) showed that robust annotations
of selectively constrained genomic regions could be produced.
As already mentioned, and as found to be true for the toxicologically important nuclear receptor PXR (pregnane X receptor)
(LeCluyse, 2001; Moore et al., 2002; Mattes, 2006), some proteins
maintain a conserved function across evolutionary time without
maintaining highly conserved primary sequences. To ﬁnd these
types of proteins, Barthet and Hilu (2008) developed an approach
that identiﬁes putative functional domains within rapidly evolving
protein sequences. Their method evaluates the constraint on amino
acid side chain composition across the open reading frames among
multiple species. The basic assumption of this approach is that functional conservation across species is indicative of selective constraints
on function; and, if selection is not acting on and therefore not evident in the primary DNA or amino acid sequence of a functionally
conserved protein, then it must be acting on another level, such as
on protein structure or on the physicochemical properties of particular amino acids. Additional methods for comparing the physicochemical variation at individual amino acid sites in proteins had previously
been developed in the context of predicting the functional impairment or difference in function of proteins. Such methods either qualitatively examine (e.g., SIFT — Sorting Intolerant From Tolerant; Ng
and Henikoff, 2003; Kumar et al., 2009) or quantify (e.g., MAPP —
Multivariate Analysis of Protein Polymorphism; Stone and Sidow,
2005) the physicochemical variation and functional impact of amino
acid differences at each site in orthologous proteins using multiple
species sequence alignments and, in the case of MAPP, evolutionary
trees inferred from them to control for phylogenetic correlation.
Finally, in addition to comparing primary sequences and the physicochemical properties of protein residues, it is possible to directly
compare the three-dimensional (3D) structures of proteins to infer
differences in function across species. A number of algorithms that
automate protein structural alignment and comparison using a variety of criteria have been developed (e.g., Taylor and Orengo, 1989;
Falicov and Cohen, 1996; Shindyalov and Bourne, 1998; Jewett et
al., 2003). Examples of online resources that implement such algorithms, ﬁnd and predict protein structures, and make 3D comparisons
include: the Structural Classiﬁcation of Proteins (SCOP) database
(scop.mrc-lmb.com.ac.uk/scop) (Murzin et al., 1995; Lo Conte et al.,
2000; Andreeva et al., 2004; Andreeva et al., 2008) with its associated
collection of manually curated structural alignments, SISYPHUS
(Andreeva et al., 2007); the ASTRAL Compendium for Sequence and
Structure Analysis (astral.berkeley.edu) (Brenner et al., 2000;
Chandonia et al., 2002, 2004); MATRAS Protein 3D Structure Comparison (biunit.naist.jp/matras/) (Kawabata, 2003); and, MinRMS: A Tool
for Determining Protein Similarity (www.cgl.ucsf.edu/research/
minrms) (Huang et al., 2000; Jewett et al., 2003). Additional tools
and resources can be found on the RCSB Protein Database (RCSB
PDB) archive (www.pdb.org) (Berman et al., 2000). However, most
of these protein structure comparison methods were created at a
time when structural analysis was the primary means of determining
homologies between remotely related proteins. Due to the explosion
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of genomics technologies and sequence databases, protein homologies are now most efﬁciently determined based on sequence analysis.
Indeed, even the SCOP database now relies on integrating sequencebased information into their protein comparison and classiﬁcation
scheme (Andreeva et al., 2008). Additionally, there is some evidence
that the functional domain architecture of proteins is more likely
the result of evolutionary descent, or phylogenetic legacy, than selection for function (Gough, 2005). This implies that methods incorporating the evolutionary relationships among proteins being compared
will fare better in the context of understanding functional similarities
and differences than comparisons based on structure alone. Therefore,
3D protein comparison across species is not currently a very useful
approach for informing interspecies similarities and differences in protein function.
Chemical examples.
To predict human effects, a number of studies
have performed genomic assessments of the interspecies differences
in liver toxicity, a common side effect of certain pharmaceuticals
and chemicals. One chemical example is the pharmaceutical, acetaminophen, which can be hepatotoxic and can cause death when
used at overdose. The mechanism of action for the hepatotoxic
response has been investigated in genomic studies in a number of
species including human cells (reviewed in Mattes, 2006). The hepatotoxicity is thought to be a result of exposure to the acetaminophen
metabolite, N-acetyl-p-aminophenol (APAP). To identify a hepatotoxic genomic signature, Beyer et al. (2007) conducted a multicenter
investigation comparing genomic changes induced in rat and mice
livers (in vivo) by the hepatotoxic APAP and by a non-hepatotoxic
APAP isomer (N-acetyl-m-aminophenol). They found that the hepatotoxic genomic signature includes c-Myc induction and further, developed a species-independent (i.e., in common to rat and mice)
genomic signature relevant to liver necrosis that includes effects on
c-Myc and Jun oncogenes. Their ﬁndings suggest some similarities in
the mechanism of action between rat and mice but fails to discuss
possible differences in the mechanism of action since the study did
not present the rat and mouse differences in gene expression. Another
chemical with hepatotoxic side effects, coumarin, was studied using
an approach called an “informational bridge” to connect gene expression responses in in vitro rat hepatocytes, in vitro human hepatocytes, and in vivo rat livers (Uehara et al., 2010). First, Uehara et al.
(2010) identiﬁed “in vivo–in vitro bridging probes” from the rat
data. Then these probes were assigned to their human orthologous
genes to identify “rat–human bridging probes” which were used to
study coumarin-induced gene expression changes in human hepatocytes. The pattern of changes in 25 genes was found to be similar
between rat and human cells but the degree of change was greater
in the rat.
Another type of comparative genomics study that focuses on interspecies comparisons of sequence-based functional elements was
utilized to identify and compare human, mouse, and rat dioxin response elements (DREs) (Sun et al., 2004). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; dioxin) mediates its effects via the aryl
hydrocarbon receptor (AhR); dioxin binds to the AhR and alters the
regulation of AhR-mediated genes. In this study, DRE-containing
genes were identiﬁed and compared across species to identify common genes. The analysis found that DRE-regulated genes differed
more between rodents and humans than between the two rodents.
These studies provide examples of real-world interspecies comparative strategies, employed in pharmaceutical development and environmental toxicology, to predict human effects.
Pathway level approaches
Both adaptive (functional) and non-adaptive (neutral) evolutionary divergence can cause differences among species, but such differences in single genes are not typically representative of the
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complexity of a trait, since very few traits are monogenic. In other
words, in most cases, multiple genes and regulatory elements interact
with each other and with environmental factors to produce a phenotype. Therefore, using interspecies comparisons of a single gene or
protein as a proxy for a phenotype of interest may be an overly simplistic method for extrapolating information from one species to
another. It has therefore been postulated that molecular pathway
comparisons will more accurately reﬂect similarities and differences
across species in complex phenotypes such as those involved in toxicity endpoints (National Research Council, 2009). A molecular pathway can be generally deﬁned as a series of linked biochemical steps
involving genes, proteins, and other biochemical factors whose activity results in the ebb and ﬂow of molecules that lead to a biological
effect. Any type of pathway, such as a metabolic pathway like the
fatty acid synthesis pathway or a signaling pathway like the insulin
receptor pathway, that is involved in the mechanism of action of a
xenobiotic and can potentially lead to an adverse outcome, can be
considered a “toxicity pathway”. Therefore, comparisons of these
pathways may be more informative biological levels for understanding the implications of interspecies extrapolation than single genes
or proteins.
The most basic approach to pathway comparison is based on the
presence or absence of orthologous proteins across species without
regards to the direct interactions among the proteins. This approach
was developed to predict the function of uncharacterized proteins,
based on the assumption that proteins that co-occur across organisms
likely function together, and that these clusters of proteins correspond to biologically meaningful pathways. Original presence/absence
methods conduct a cluster analysis of organism-by-protein matrices
that are either based on simple presence/absence binary data (i.e., 1 =
protein present in that organism; 0 = protein absent) (Pellegrini et
al., 1999; Liao and Noble, 2002; Wu et al., 2003) or that are modiﬁed
by a measure of sequence similarity represented as continuous data
(Date and Marcotte, 2003; Jothi et al., 2007). Improvements to the
basic presence/absence methods extend those approaches from comparisons of co-occurring proteins to comparisons of co-evolving proteins. By incorporating the evolutionary relationships among the
species being compared into their algorithms (Barker and Pagel, 2005;
Zhou et al., 2006; Barker et al., 2007; Cokus et al., 2007), these methods
provide additional information on the gain or loss of proteins in an evolutionary context. A related approach, also developed for the characterization of proteins and discovery of pathways, is based on comparing
the size of gene families across species. As with the presence/absence
approaches, some of these gene family size methods are correlationbased (Ranea et al., 2007) and others are coevolution-based (Cordero
et al., 2008; Ruano-Rubio et al., 2009). Finally, there are analogous
approaches that use binary presence/absence data, but that tally the
presence/absence of other factors instead of tallying the pathway proteins. For example, Tun et al. (2006) analyze the presence/absence of
interactions between the proteins, while Kastenmuller et al. (2009)
and Gonzalez and Zimmer (2008) developed algorithms that compare
pathways based on the presence/absence of phenotypes, including continuous, or quantitative, phenotypes. The latter two methods were
developed to understand the biochemical basis of phenotypic traits,
and they work by linking phenotypes to associated metabolic processes.
Because toxicity endpoints are phenotypes, this method has potential
for discovering and informing differences in toxicity pathways across
species.
Unlike most of the aforementioned approaches, other types of
interspecies pathway comparison take into account the interactions,
or reactions, among the enzymes and compounds in the pathways
being compared. One such approach analyzes the interacting functional domain patterns in protein–protein interactions across multiple species (Chen et al., 2008) — domains being the structural and
functional units of proteins. The assumption underlying this method
is that shared interacting domain patterns across species are

indicative of shared functions; and according to the authors, this
method achieves better than 95% accuracy at predicting gene function
in humans. However, most of the approaches incorporating interaction information into interspecies pathway comparisons were not developed not as a means to predict and characterize the functionality
of proteins and pathways. Most were created as an additional
means to uncovering the evolutionary relationships among organisms, and especially among microbes whose evolutionary relationships can be intractable to standard sequence-based phylogenetic
analyses due to the complicating factor of horizontal gene transfer.
Approaches were therefore developed that attempt to reconstruct robust phylogenetic trees using functional pathway information
(Heymans and Singh, 2003). These approaches typically model their
molecular pathways as graphs (see Deville et al., 2003 for overview
of graph models), align the graphs across one or more species, and
then assess and score the similarity among the graphs in one way
or another. For example, one web server (www.jaist.ac.jp/
~clemente/cgi-bin/phylo.pl) (Clemente et al., 2007) graphs comparisons of pathway structure using different measures of protein functional similarity: measures based on enzyme class (hierarchical
similarity) (Tohsato et al., 2000; Chen and Hofestadt, 2004), information content similarity (Tohsato et al., 2000; Pinter et al., 2005), or
gene ontology similarity (Clemente et al., 2005). It pulls pathways
from the KEGG database (www.genome.jp/kegg/pathway.html) and
currently allows for comparison across 13 species including mouse,
rat, and human. Other approaches assume that functional similarities
are inherent in primary sequences and so use a measure of sequence
similarity from either pairwise (Ovacik and Androulakis, this issue) or
multi-species sequence alignments (Forst and Schulten, 1999, 2001)
to compare topologically aligned pathway graphs. Even though many
of these approaches were developed for studying evolution in microbes,
their potential usefulness to risk assessment is in providing the capacity
to align and compare pathways across species, regardless of the taxa.
Methods that highlight the differences between species in their
use of similar pathways and similar reactions within pathways may
be especially useful for informing interspecies differences in toxicity
pathways. One such method, the Metabolic Pathway Alignment and
Scoring (M-PAS) method, is another graph alignment approach but
is based on discovering conserved pathways from “building blocks”
of aligned reactions that account for reaction direction (Li et al.,
2008). This method integrates enzyme function and sequence similarity scores into one similarity score and aligns networks of these
building blocks, resulting in aligned pathways with quantiﬁed levels
of conservation, giving insight into the differences between species.
Although currently limited to two-species comparisons and to linear
(acyclic) pathways, Li et al. (2008) suggest the M-PAS can be expanded to more complex graph topologies and to multi-species
comparisons.

Chemical example.
In mice, PPARα regulates hepatic lipid metabolism, but there is an absence of data on the mechanism of PPARα in
humans. To address data gap, Rakhshandehroo et al. (2009) compared gene level and pathway level approaches by assessing the
genomic response in primary hepatocytes exposed to the PPARα
agonist pharmaceutical, Wy14643. Their comparison of mouse and
human hepatocyte (in vitro) responses found little overlap at the
gene level but a greater overlap at the pathway level. Common pathways included lipid metabolism and known PPARα target pathways
(e.g., HMGCS2). In addition, human speciﬁc PPARα-regulated pathways for xenobiotic metabolism and apolipoprotein synthesis were
identiﬁed. Their results suggest some common and some divergent
liver responses to PPARα between rat and human. Identiﬁcation of
such human-speciﬁc and in-common pathway effects can improve
our knowledge about species-speciﬁc mechanistic steps and aid the
prediction of human health effects.
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Network level approaches
Even pathways are relatively simplistic models of extremely complex biological processes. In reality, pathways overlap, interact with
each other, and are components of highly complex non-linear molecular networks (see Wuchty et al., 2006 for a review of biological network architecture). The nodes of molecular networks typically
represent molecular entities like genes, proteins, mRNA levels, or metabolites, and the edges connecting these nodes represent the functional relationships among those entities, such as protein–protein
interactions, gene modiﬁcations, transcriptional regulation, etc.
(Han, 2008; Schadt, 2009). Complex traits, including common
human diseases, originate from more than single gene disruptions;
they stem from a complex interaction between an organism's molecular networks (genetic and epigenetic) and a broad array of environmental factors including exposure to environmental toxic agents.
Recent research in systems biology has shown that molecular networks both respond to and, in effect, cause common human disease
through perturbations to complex interconnected molecular interactions; and that therefore, they may be more relevant to understanding diseases than are a small number of genes or single pathways
(Chen et al., 2008; Schadt, 2009). Because of this, comparisons of
entire molecular networks and/or of interacting sub-networks underlying or associated with toxicological endpoints should provide yet
another method for informing interspecies differences in a risk
assessment context.
Approaches to interspecies network comparison share similarities
with methods used for pathway comparison, since both involve graphical models. However, additional challenges not encountered by most
pathway comparisons include the non-linear structure of networks,
the exponential growth of the size of the alignment graphs with
increasing number of aligned networks, and the dynamic nature of networks (Han, 2008). In addition, molecular networks are not static; they
have “dynamic modularity” in that they can vary over time and space
(Kholodenko, 2006; Han, 2008). Nevertheless, several approaches to
network comparison have been developed recently and, as occurred
within the now mature ﬁeld of sequence alignment, improvements in
this area are expected to continue progressing quickly. In regards to interspecies network differences, there are two general types of relevant
network comparisons: network alignment approaches, including global
and local network alignment as well as network querying (see review
by Sharan and Ideker, 2006), and clustering approaches.
Global and local network alignment involve the comparison of two
or more networks and have mainly been used to elucidate network
structure and to identify sub-networks conserved across species and
therefore likely to represent functional biological units. Network
querying, on the other hand, is analogous to searching a sequence
database for a match to an input sequence; it involves graph-mining
techniques that search for sub-networks similar to the input query
in a given network or network database. These methods could be
useful for informing interspecies differences in the context of
chemical risk assessment both by enabling the discovery of
homologous network structures and by aiding in the identiﬁcation of
orthologous proteins, orthologous protein–protein interaction pairs
(interologs), and signaling and regulatory pathways across species.
Network alignment and querying algorithms consist of scoring functions and search algorithms. Most network alignment approaches
developed to date conduct global network comparisons by scoring the
homologous node pairs and their interactions, constructing network
alignment graphs from these, and then searching these sets of graphs
for the highest scoring alignments (e.g., Koyuturk et al., 2004; Sharan
et al., 2005a, 2005b; Flannick et al., 2006; Pinney et al., 2007). These
two essential parts of network alignment – a scoring framework that
represents current knowledge pertaining to the network's entities and
evolution, plus an algorithm for the rapid identiﬁcation of conserved
alignments from an exponentially large set of possible alignments –
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are problems with multiple solutions. For example, one solution to the
scoring problem uses a probabilistic function (e.g., PATHBLAST: Kelley
et al., 2003), while another employs an overall conﬁdence score based
on the combined statistical signiﬁcance of sequence similarity, number
of conserved interactions, and functional relatedness (e.g., HopeMap:
Tian and Samatova, 2009), and yet others adopt evolution-based scoring (e.g., MaWISh: Koyuturk et al., 2006; and, Graemlin: Flannick et
al., 2009) or incorporate probabilistic models of evolution (e.g., Berg
et al., 2004; Berg and Lässig, 2006; and, CAPPI: Dutkowski and Tiuryn,
2007, 2009). Continued improvements to scoring functions, including
more phylogeny-based approaches, are expected as our understanding
of molecular network evolution increases.
As with scoring functions, several approaches to the problem of
the search algorithm have been developed. However, while the scoring problem is in the realm of statistics, probability, and evolutionary
and molecular biology, the search algorithm problem sits squarely in
the ﬁelds of graph theory and in the latest extension of graph theory:
complex network theory. Solutions to the search problem have to
address the issues of speed, scalability, and accuracy. Most current solutions to the search problem include approaches, such as progressive
alignment, that use a stepwise, iterative algorithm for ﬁnding locally
optimal solutions based on the score (a “greedy heuristic”). A heuristic is employed because the growth of the alignment graphs is a limiting factor in terms of computational cost. Indeed, one large hurdle
for many of these approaches has been in scaling up beyond pairwise
comparisons (Kelley et al., 2003; Koyuturk et al., 2004, 2006; Sharan
et al., 2005a; Zaslavskiy et al., 2009) to multi-species network comparisons (Sharan et al., 2005b; Flannick et al., 2006, 2009;
Alexeyenko and Sonnhammer, 2009; Dutkowski and Tiuryn, 2009;
Qian and Yoon, 2009; Tan et al., 2009). In addition, a non-heuristic
pairwise comparison solution to the search algorithm problem has
also recently been proposed by Klau (2009). According to the author,
this algorithm is adaptable to many types of networks and is scalable
to multi-network comparisons; it works by mathematically redeﬁning the global alignment graph in such a way that a search for the
optimal structural alignment is possible.
Creative modiﬁcations of these approaches, as well as alternatives
to network alignment approaches, have also recently been developed.
For example, whereas most alignment graphs are composite graphs
in which nodes are merged representations of orthologous relationships among molecules like genes and proteins connected by edges
representing interactions, there are network alignment approaches
that instead deﬁne the nodes as the interactions or as sets of interactions. One such approach, the “direct-edge-alignment” method, uses
domain–domain interactions across two networks to construct alignable pairs of edges and thereby directly infers a protein–protein interaction network (DOMAIN: Guo and Hartemink, 2009). Another
approach creates networks of interacting pathways where the nodes
are pathways and the edges between them are the compounds they
exchange or share (Mazurie et al., 2008). On the other hand, network
comparison approaches that do not even use network alignment to
address interspecies questions have also been developed. Because
network alignment can be limited in coverage if dependent on orthologous relationships, and because it is potentially sensitive to errors in
network topology, some investigators have instead relied on graph
clustering algorithms for comparisons across networks. For example,
there are connectivity-based clustering approaches (e.g., Bergmann et
al., 2003; Yamada et al., 2006; Narayanan and Karp, 2007; Borenstein
et al., 2008; Erten et al., 2009; Wiles et al., 2010), data integration
clustering approaches (Kelley and Ideker, 2005; Linghu et al., 2008;
Alexeyenko and Sonnhammer, 2009; Wang et al., 2009), and probabilistic clustering approaches (Stuart et al., 2003) that have successfully
combined and compared a variety of data types across multiple species. In addition, at least one approach integrates network alignment
methods with graph clustering algorithms to compare protein functional similarity across species (Ali and Deane, 2009).
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Discussion
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Strengths and weaknesses of approaches
Even though the quantity of available molecular information for
different species is increasing rapidly, we face a variety of technical
and experimental issues when using these data in interspecies
comparisons. Genome-wide data are full of noise (false positives)
and annotation from one species to another can be unreliable. Annotation of genomes and experimental arrays, as well as the availability
of genomic data and experimental platforms, are technical issues that
impact quantity, quality, and completeness of data sets. With pathway and network comparisons in particular, we have to deal with
this dilemma of incomplete data sets when evaluating whether or
not the comparisons accurately represent the systems being modeled.
For example, given a protein–protein interaction network, if the set of
interactions being examined is incomplete, then the absence of an
observation assumed to indicate non-interaction is potentially erroneous. In addition to incomplete data sets, we also have the problem
of inconsistent experimental conditions across studies. Differences
across studies in coverage of genome-wide assays, in experimental
design, and in analyses can impact conclusions drawn when comparing results from such studies. Therefore, comparison methods that are
robust to data gaps and inconsistencies such as these are needed. To
account for shortcomings in a way that is useful in the context of
risk assessment, performance estimates of the models and comparison approaches used will be critical.
Of all levels of interspecies molecular comparison, the comparison
of single entities such as DNA sequences, protein functional domains,
whole protein structures, or even single amino acid mutations, has
the longest history and therefore is the best-tested set of methodologies. Sequence comparison methods are robust, well-understood, and

known impact

Ease of Manipulating Information

The tools and concepts of comparative genomics, including
genome-wide measurements of biological entities such as proteins,
expressed genes, metabolites, and DNA methylation (i.e., proteomics,
transcriptomics, metabolomics, and genomic methylation), have the
power to greatly enhance toxicology and risk assessment. Comparative genomics can provide a means for identifying toxicity pathways,
mechanisms, and biomarkers, and their differences across species. In
the toxicity pathway-based approach to risk assessment, with its
envisioned transition to a greater reliance on in vitro assays, comparative genomics will be crucial for establishing mechanistic links and
quantitative relationships between laboratory animal studies and
human cell-based in vitro assays. Thus, the comparative genomics
and computational approaches compiled here will be critical to
addressing one of the challenges in human health risk assessment:
reducing the uncertainty caused by extrapolated inferences about
toxicological exposure and health effects from test animals to humans
(Fig. 1).
It is beyond the current state of the science to produce a guide on
using genomics for extrapolating inferences across species in environmental chemical risk assessment. Instead, by categorizing the different types of approaches, starting with interspecies comparisons at
the relatively simplistic level of genes and proteins and ending with
comparisons at the systems biology level of molecular networks, we
have presented an overview of the main types of approaches available to researchers (Fig. 2). We also provide examples of several
widely used genomics databases and publicly available interspecies
comparison tools and resources in Tables 1 and 2 respectively. In
this section, we evaluate the strengths and weaknesses of these
major types of interspecies molecular comparison approaches in
terms of their potential for implementation in risk assessment. Furthermore, we discuss the challenges and overarching recommendations for research that will help bridge the gap between current
comparative genomics approaches and application to risk assessment.

Sequence Level Comparisons
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Fig. 2. Molecular-based interspecies comparisons. Simpliﬁed depiction of three levels
of molecular comparisons for extrapolating inferences about mechanism of action
across species (showing rat and human as examples) using comparative genomics. In
reality, pathway models tend to involve more nodes and interactions than depicted,
and may also have non-linear components; in addition, molecular network models
using genome-wide data will be far more complex in terms of nodes and interactions/
linkages than depicted in the cartoon above, giving them the appearance of “hairballs”.

widely used. While minor issues with ascertaining orthology do pertain to these approaches, they do not suffer from the larger problem
of incomplete datasets. In addition, techniques to predict functional
changes based on sequence or structural differences have proven useful in hypothesis generation and weight-of-evidence schema in the
context of gene characterization and discovery. However, it is not
easy to predict how a functional change in a sequence, such as an enzyme critical to the mechanism of action, may impact a toxicological
outcome. Although the reductionist approach is comfortable and
attractive in both science and risk assessment, the isolation of complex biological problems, like toxicity, to the level of a gene or protein
may mean missing the mark more often than not. In other words,
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Table 2
Selection of publicly available online tools for interspecies molecular comparisons.
Tool/resource
Protein & gene comparison approaches
GERP.............................................................................................................................
http://mendel.stanford.edu/SidowLab/downloads/gerp/index.html
MAPP............................................................................................................................
http://mendel.stanford.edu/SidowLab/downloads/MAPP/index.html
MATRAS......................................................................................................................
http://biunit.aist-nara.ac.jp/matras
MINRMS......................................................................................................................
http://www.cgl.ucsf.edu/Research/minrms
PANTHER.....................................................................................................................
http://www.pantherdb.org
PHAST...........................................................................................................................
http://compgen.bscb.cornell.edu/phast
ProPhylER...................................................................................................................
http://www.prophyler.org
RIO.................................................................................................................................
http://rio.janelia.org/
SIFT................................................................................................................................
http://sift.jcvi.org
SISYPHUS....................................................................................................................
http://sisyphus.mrc-cpe.cam.ac.uk/sisyphus
Pathway Comparison Approaches
GeneCensus................................................................................................................
http://bioinfo.mbb.yale.edu/genome
PATHBLAST.................................................................................................................
http://www.pathblast.org
Phylogenomic reconstruction from non-genomic data............................
http://www.jaist.ac.jp/~clemente/cgi-bin/phylo.pl

Description
Genomic Evolutionary Rate Proﬁling: identiﬁes constrained elements in multiple sequence alignments
by quantifying substitution deﬁcits (Cooper et al., 2005)
Multivariate Analysis Of Protein Polymorphism: predicts constraint and the impact of polymorphisms;
maps these onto predicted protein structures (Stone and Sidow, 2005)
MArkovian TRAnsition of Structure evolution: program for 3-D protein structure comparison (Kawabata
and Nishikawa, 2000; Kawabata, 2003)
MINimal Root-Mean-Squared-Distance: Tool for determining protein similarity through 3D alignment
(Jewett et al., 2003)
Protein Analysis THrough Evolutionary Relationships (Thomas et al., 2003; Mi et al., 2005)
PHylogenetic Analysis with Space-Time models: Freeware package for comparative and evolutionary
genomics (Siepel et al., 2005)
Protein Phylogeny and Evolutionary Rates: Predicts the impact of coding polymorphisms using
phylogenetic conservation (Binkley et al., 2010). Includes MAPP algorithm. (Stone and Sidow, 2005)
Resampled Inference of Orthologs: Estimates the reliability of protein orthology using bootstrap values
(Zmasek and Eddy, 2002)
Predicts whether an amino acid substitution affects protein function based on sequence homology and
the physical properties of amino acids (Ng and Henikoff, 2003; Kumar et al., 2009).
Structural 3D alignments for proteins with topological irregularities (Andreeva et al., 2007)

Database tool for comparing genomes, including pathway analysis of activity levels. Includes Tree
Viewer & PathwayPainter modules (Lin et al., 2002)
Global alignment graph method (Kelley et al., 2003)
Graph comparisons of metabolic pathway structure using different measures of protein functional
similarity (Clemente et al., 2007)

Network comparison approaches
Cytoscape....................................................................................................................
http://www.cytoscape.org
DOMAIN......................................................................................................................
http://www.cs.duke.edu/~amink/software/
Graemlin.....................................................................................................................
http://graemlin.stanford.edu

Open source bioinformatics platform used for analyzing and visualizing complex graph data. Free and
user-friendly network visualization tool (Sharan et al., 2007)
Pairwise network alignment for protein-protein interaction networks that uses a direct-edge alignment paradigm based on domain–domain interactions (Guo and Hartemink, 2009)
Network alignment framework for ﬁnding conserved modules in a set of networks or for ﬁnding
matches to a particular module within a databse of interaction networks; 2.0 version includes a
parameter learning algorithm for the scoring function. (Flannick et al., 2006; Flannick et al., 2009)
IsoRank & IsoRankN................................................................................................ Tools for global multiple network alignment of protein–protein interactions for yeast, ﬂy, worm,
http://groups.csail.mit.edu/cb/mna/
mouse, and human. IsoRank algorithm is similar to Google's PageRank (Singh et al., 2008); IsoRankN
tool is based on spectral clustering, is error-tolerant, and computationally efﬁcient (Liao et al., 2009)
NeMo............................................................................................................................ A Cytoscape Plug-in that identiﬁes network modules (Rivera et al., 2010)
http://baderlab.bme.jhu.edu/baderlab/index.php/NeMo
NetGrep....................................................................................................................... Fast network schema searches in interactomes (Banks et al., 2008)
http://genomics.princeton.edu/singhlab/netgrep/
NetworkBLAST.......................................................................................................... Analyzes protein interaction networks across species to infer evolutionarily conserved protein
http://www.cs.tau.ac.il/~bnet/networkblast.htm
complexes; capable of multiple network comparisons (Sharan et al., 2005a; Kalaev et al., 2008)
PATHICULAR.............................................................................................................. A Cytoscape Plug-in that identiﬁes regulatory path motifs, enriched paths in integrated physical nethttp://bioinformatics.psb.ugent.be/software/details/pathicular
works connecting cause-effect genes in perturbational expression data (Joshi et al., 2010)

these small entities do not exist and operate in isolation; their connections and interactions with other molecules may have ramiﬁcations beyond their perceived functional change; or on the other
hand, their connections and interactions could provide resiliency —
a damping of effects. However, in addition to computational comparisons of genes, proteins, and other sequences from genomic datasets,
there are also targeted experimental approaches that can address and
help quantify interspecies comparisons at this biological level of organization, such as relative expression, gene knock-down, and enzyme
activity assays (see Benson and Di Giulio, 2007 for overview). Because
of this, we expect that many initial attempts to incorporate interspecies molecular comparisons into risk assessment and to quantify differences will be attempted at this level.
More biologically relevant modeling of toxicological perturbation
will happen at the level of pathways and networks. These “systems”
may have resiliency and may have weaknesses that are not evident
in comparisons of single gene or protein differences. Pathway comparisons ﬁt nicely into the NRC envisioned framework of toxicity
pathway-based risk assessment. They provide a physiological context
for protein and gene changes in a model that may better capture the

key events of a mechanism of action. Approaches for comparing pathways and for measuring conservation of pathway function are still
developing and are still mainly being used for understanding prokaryote evolution. While such approaches provide the structure
needed for interspecies pathway comparison and are becoming better
at extracting information about evolutionary relatedness based on
functional systems, they do not yet encode a means for quantifying
functional changes or their physiological implications.
Networks are a natural extension of pathway models; they are as
unbiased a molecular representation of a biological system as is possible. In addition, because pathways are essentially simpliﬁed networks, there is no reason that network comparison approaches
cannot be applied to them — there simply has been a separation of
goals driving the two approaches. Networks can model anything we
can measure including the functional relationships among molecules
such as: gene modiﬁcations, protein–protein interactions, transcriptional regulation, DNA methylation, pre- and post-translational
modiﬁcations, metabolic reactions, siRNA–mRNA interactions, etc.
Because molecular network models of genome-wide processes are
all-encompassing in nature and constructed from unbiased empirical
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data, and because they display an evolved robustness to perturbations (Albert et al., 2000; Wuchty et al., 2006; Zhu et al., 2007;
Costa et al., 2008), molecular networks are the most comprehensive
and biologically relevant models available for understanding physiological responses to environmental chemicals and are expected to
greatly enhance 21st century risk assessment (Edwards and Preston,
2008). However, among the approaches discussed here, interspecies
network comparisons have the potential to suffer the most from
the problem of incomplete information resulting from disparities in
availability and annotation of data across, as well as within, species.
Nevertheless, a low percentage of missing or mis-annotated pieces
of information from a complex model of a biological system such as
a molecular network, are less likely to affect overall analyses and conclusions than are the unknown and missing data left out due to the
simplicity of models such as comparisons of cherry-picked genes
and proteins.
Challenges and recommendations for risk assessment
The interspecies comparison approaches compiled and discussed
here were all developed for purposes other than risk assessment,
such as for inferring evolutionary relationships, for predicting functional sequences and conserved pathways, for hypothesis generation
in ﬁnding and testing disease-related processes, etc. The integration
of genomics-based approaches such as these with in vivo and in
vitro toxicity testing data will enhance the identiﬁcation of toxicity
pathways, improve our understanding of similarities and differences
in mechanism of action among species, and will also aid in the development of virtual tissue models. A major challenge for the future paradigm of human health risk assessment is in translating approaches like
these into ways of extrapolating inferences qualitatively, and ultimately
quantitatively, about toxicological outcomes from test animals to
humans. Addressing this challenge will require the development of
genomics-based risk assessment methods. We propose that, with further
reﬁnement and testing, computational interspecies comparison approaches, such as those discussed here, can be adapted for this use.
Additionally, molecular data can be incorporated into the current
paradigm of risk assessment as well. Information on molecular differences between test animals and humans can be applied qualitatively
by using a weight-of-evidence approach to judge whether or not to
adjust the interspecies uncertainty factor (Box 1) and/or whether or
not the animal data are relevant to humans. Data from gene/protein,
pathway, and network comparisons could contribute to the weight
of evidence about interspecies differences for a mechanism of action
that may already include, for instance, known differences in the outcomes and/or regulation of the outcome across species. For example,
in the case of chemicals that affect androgen action, extensive information known about the regulation of male sexual differentiation
by androgens across vertebrates (Hotchkiss et al., 2002; Wilson et
al., 2004, 2007; Hartig et al., 2007) would be part of the weight-ofevidence that, combined with gene, pathway, and/or network ﬁndings, may inform a picture of high or low similarity of the mechanism
of action across test species and humans. In this qualitative application, the degree of change in the interspecies uncertainty factor
would be based on scientiﬁc judgment and precedent. Indeed, current and future risk assessment decision-making processes are
based, in part, on scientiﬁc judgment after weighing multiple factors including data sources, data coverage, data quality, and exposure scenarios.
The larger challenge is in coming up with methods to utilize the
ﬁndings of these comparative approaches in a quantitative manner.
For example, while interspecies differences between gene and protein sequences are easy to quantify, the functional differences and
phenotypic differences they may or may not cause are not easy to
quantify. This difﬁculty in quantifying functional and phenotypic
divergence can then be exacerbated by a lack of information on the

Box 1
Uncertainty factors in human health risk assessment
Although risk assessment guidelines and methods vary, the
issue of uncertainty pertains regardless. As one example of
accounting for uncertainty, the EPA's Integrated Risk Information System (IRIS) applies numerical correction factors to the
reference doses (RfDs) and reference concentrations (RfCs) in
human health risk assessment. Different uncertainty factors
are used to account for: 1) variation in susceptibility among
humans (intraspecies uncertainty; see Mortensen and Euling
(this issue) for a review of approaches); 2) uncertainty in extrapolating from effects in animal models to effects in humans
(interspecies uncertainty); 3) uncertainty in extrapolating from
subchronic exposure data to chronic exposure; 4) uncertainty
in making inferences based on a lowest-observed-adverseeffect-level (LOAEL) instead of a no-observed-adverse-effectlevel (NOAEL); and, 5) uncertainty due to incomplete information on a chemical (database uncertainty).
For the interspecies uncertainty factor, the default value of
10 1 (10X) is composed of a toxicodynamic (TD) portion of
10 0.5 (~3.3×) and a toxicokinetic (TK) portion of 10 0.5
(~3.3×). This uncertainty factor, in any given assessment,
can be adjusted if the available data about interspecies differences in TD and/or TK suggest a similarity or difference
between animal models and humans (see Fig. 1). If data on
chemical mechanism of action support a similarity or dissimilarity in humans as compared to the animal test model, then the
relevant portion of the interspecies uncertainty factor can be
adjusted. For example, in the IRIS Tox Review for ethylene glycol monobutyl ether (EGBE), the TD portion of the interspecies
uncertainty factor was reduced to 10 0 (1×) based on data indicating that humans are less sensitive than the test animal for
the critical effect (U.S. EPA, 2010).

relative importance of the genes or proteins to the chemical mechanism of action. On the other hand, less reductionist approaches,
such as those involving pathway and network comparisons across
species, show more potential for eventual quantitative application
to risk assessment, because they have the capacity to measure perturbations on a systems level. However, for quantitative application,
methods shown to be robust to data gaps and data inconsistencies
and that include performance estimates are still needed.
Even without methodologies reﬁned speciﬁcally for application to
risk assessment, interspecies network and pathway perturbation
models based on existing methods can be used now to generate testable hypotheses for human cell-based in vitro assays that can then be
used qualitatively, and eventually quantitatively, in risk assessment.
For example, as illustrated in Fig. 3, given chemical X with known
adverse outcomes in rat in vivo studies: ﬁrst, a rat network perturbation model could be developed; second, the rat and human networks
could be compared; third, based on differences and similarities
highlighted by the interspecies network comparison, human in vitro
assays could be developed and performed; fourth, in vitro perturbations could be mapped back to the compared networks; and, ﬁnally,
human in vivo outcomes could be inferred. Furthermore, the pathway
and network comparison approaches discussed here that do not
depend on evolution-based scoring or phylogenetic information
could also be adapted to address another challenge in the new risk
assessment paradigm: extrapolating perturbation data from in vitro
assays conducted in one cell or tissue type to the cells, tissues, and/
or organs relevant to the critical effect in vivo. The pharmaceutical
example of the study of Wy14643 (Rakhshandehroo et al., 2009)
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Fig. 3. Interspecies comparisons and human relevance — a modiﬁed parallelogram approach for integrating in vivo, in vitro, and computational approaches in interspecies extrapolation of toxicity perturbation. The parallelogram approach proposed by Nesnow (2004) and referred to by the National Research Council (National Research Council, 2006) is
modiﬁed here by the incorporation of computational comparative genomics approaches. Using rat and human as examples: 1) a rat network perturbation model is developed
based on in vivo data; 2) the rat and human networks are computationally compared; 3) differences and similarities found by the interspecies network comparison are tested
via human in vitro assays (e.g., primary human cell lines); 4) quantiﬁed in vitro perturbations are mapped back to the compared networks; and, 5) human in vivo outcomes are
inferred. In addition, rat in vivo assays, driven by network-based hypotheses or otherwise (as represented by the white arrows), can inform the rat network model and the compared network model.

highlights the utility of both gene-level and pathway-level effects as a
method to qualitatively identify species-dependent and speciesindependent gene and pathway effects. With information on multiple
species, mechanism of action predictions can be improved for the
species of interest.
We conclude that comparative genomics data and methodologies will
meet a critical need in environmental chemical risk assessment for understanding interspecies differences and for characterizing the uncertainties
resulting from extrapolating inferences across species. To make advancements in chemical risk assessment through better understanding interspecies differences in mechanism of action, we propose that research
and development efforts focus on current computational methodologies,
as compiled and discussed here (see Table 2 in addition to literature cited
in the text), and on sources of publicly available genomic information (see
Table 1), that can be utilized and adapted for the purpose of comparing biological systems and processes across species and for deﬁning toxicityinduced responses in species of interest. Speciﬁc areas ripe for further research include the following:
• Chemical case studies applying single gene or protein level comparisons to existing risk assessment processes.
• Chemical case studies based on the research paradigm outlined in
Fig. 3 and described herein.
• The development of approaches for quantifying the functional
changes and physiological implications associated with detected molecular differences across species in pathway comparison approaches.
• Network comparison methods that are shown to be robust to data
gaps and that include performance estimates for more quantitative
applications.

• Improved characterization of the differences and similarities in
pathway and network models of unperturbed systems among species most relevant to human and ecological risk assessment.
In summary, modeling chemical perturbations in test animals onto
pathways and networks that can then be compared to human pathways
and networks will bring human health risk assessment one step closer to
the NRC's 21st century vision of tethering pathway perturbations
directly to human disease instead of basing the mechanism of action
on animal models. By querying interspecies comparative network
and/or pathway models of chemically-induced perturbations and quantifying the differences, it should then be possible to move closer to
developing quantitative measures of interspecies differences for use in
risk assessment.
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